weSure Global Tech: Who Allocates Ayalon's Cash And Where It Goes
The main article already showed that Ayalon is weSure's earnings engine. This follow-up shows that about NIS 105 million moved up from Ayalon to weSure as dividends in 2025, but at the parent level that cash was already being reallocated between shareholder payouts, old-debt cleanup, and new verticals that still have not proved their returns.
The main article already established the basic structure of the story: Ayalon is the engine that currently generates the profit and the capital cushion, while the US platform, non-bank credit, and provident-fund activity still need proof. This follow-up is about a different question. Once the cash leaves Ayalon, who actually decides what happens to it next.
The filings point to a fairly sharp answer. In 2025 about NIS 105 million moved up from Ayalon to weSure through dividends. But once that money reached the parent, it no longer behaved like insurer cash. It entered a holdco-level allocation framework that was simultaneously funding shareholder distributions, the repayment of an old acquisition loan, and the setup of new financial verticals. At the same time, the group did not rely only on Ayalon's dividend stream. It also raised debt and equity at the parent, while fresh equity entered Ayalon itself during the same year.
This is no longer mainly an underwriting question. It is a capital-allocation question. Ayalon generates the surplus capital. weSure Global Tech decides whether that capital becomes a dividend, lower leverage, or fuel for businesses that still have not demonstrated return on equity.
| Move | Amount | Layer | Why it matters |
|---|---|---|---|
| Dividends from Ayalon, paid in 2025 and attributable to weSure | About NIS 105 million | Ayalon to parent | Shows that Ayalon can already upstream real cash |
| Dividends paid by weSure to its own shareholders in 2025 | NIS 65 million | Parent to shareholders | Part of the upstream cash did not stay inside the group |
| Full repayment of the old acquisition bank loan | NIS 90 million | Parent | Cleans up the legacy loan and releases old covenants and collateral |
| weSure bond issuance and series expansion | About NIS 195.6 million gross proceeds | Parent | Shows the parent was not relying only on Ayalon dividends |
| Private placement of weSure shares | About NIS 150 million gross | Parent | Adds another layer of capital flexibility above Ayalon |
| Private placement of Ayalon shares | About NIS 150 million | Ayalon | Fresh equity also entered the insurer layer |
| Initial investment in Glovaltak Finance | NIS 5 million | Parent to new arm | First capital seed into a business that has not yet proved returns |
| Intercompany credit line for Glovaltak Finance after the balance-sheet date | Up to NIS 50 million | Parent | A potential capital call that has already been opened |
Where Allocation Starts
Everything in this continuation starts with one basic fact: Ayalon is no longer just profitable on paper. It is already generating regulatory capital that can move up the chain. The dividend policy approved at Ayalon in November 2024 targets at least 40% of annual comprehensive profit as long as the solvency target is maintained. In 2025 that policy stopped being theoretical. Ayalon paid an additional NIS 30 million dividend in April 2025 relating to 2024, an interim NIS 75 million dividend in September 2025 relating to 2025, and an additional NIS 50 million dividend in December 2025 relating to 2025.
weSure's share in those three payouts was about NIS 21 million, about NIS 52 million, and about NIS 32 million respectively, or about NIS 105 million in total. That matters because it turns Ayalon from an accounting earnings engine into an actual upstream cash generator.
The solvency layer also does not look stretched here. In the presentation, Ayalon reports a 136% solvency ratio with transitional measures and 129% without them as of June 30, 2025, after deducting the NIS 75 million and NIS 50 million dividends declared after the solvency date. In other words, the 2025 cash that moved up to weSure was backed by genuine capital room, not by last-minute accounting optimism.
This chart is not meant to argue that every shekel from Ayalon was traced to a single use. It does make the key point visible. Once cash moved up, it immediately sat next to both shareholder distributions and debt cleanup at the parent. That is the point where the story stops being “Ayalon paid a dividend” and becomes “weSure allocated capital.”
At The Parent Level, This Is A Capital-Control Room, Not An Operating Insurer
Once the reading moves to the solo parent, it becomes clear how different the economics of weSure Global Tech are from those of an operating insurer. Parent-level management fees, investment income, and other income totaled just NIS 16.1 million, against NIS 30.8 million of G&A and financing expense. The item that closed the gap and brought profit attributable to shareholders to NIS 265.6 million was one line, NIS 280.3 million of profit from investees. In plain terms, the parent is not generating the story itself. It lives on what comes up from the holdings, above all from Ayalon.
That is exactly why capital allocation matters more here than operating profitability at the parent. At the end of 2025, weSure had about NIS 371 million of current assets at the solo level, including about NIS 369 million of cash and cash equivalents. Against that sat about NIS 251 million of solo financial liabilities, of which only about NIS 32 million were current.
The move that changed the structure most visibly in 2025 was the full repayment of the old bank loan that had financed the acquisition of control in Ayalon. The company repaid NIS 45 million in March 2025 and another NIS 45 million in October 2025, and after the full repayment the old covenants and collateral were released. That is a real improvement. It removes the legacy mortgage hanging over the parent layer.
But leverage did not disappear. It simply changed form. Alongside the repayment of the bank loan, the company still reports NIS 25 million outstanding on the seller loan, NIS 39.3 million outstanding to Rahmani Investments, and about NIS 199.6 million par value of Series A bonds.
The funding side shows the same point. The parent was not relying only on Ayalon's dividend stream. In September 2025, weSure issued bonds and warrants to the public for gross proceeds of about NIS 166.2 million. In October 2025, it expanded that series in a private placement to Clal Insurance for another gross NIS 29.4 million. In December 2025, it also completed a private placement of its own shares for about NIS 150 million gross.
This chart sharpens a point that is easy to miss. This is not a one-way dividend pump. The group both pulled cash up from Ayalon and raised fresh capital at the parent, while also raising fresh capital inside Ayalon itself. So the correct reading of 2025 is not “Ayalon funds everybody.” The correct reading is “the group is rebuilding its capital stack around Ayalon.”
The Ayalon move matters especially. In August 2025, Ayalon completed a private placement of shares and warrants for about NIS 150 million. That means group management is not treating Ayalon only as an extraction channel. It is also willing to reinforce the insurer capital layer when it chooses to expand activity and preserve flexibility.
Where The Next Shekel May Go
This is where the difference between 2025 as a distribution year and 2026 as a test year becomes visible. If Ayalon could still be read mainly as a profit engine that sends dividends upward during 2025, from late 2025 onward that same surplus capital is already facing at least two new potential capital sinks.
The first is Glovaltak Finance. The subsidiary was established in August 2025, and in October 2025 weSure injected NIS 5 million into it through a subordinated capital note designed both to meet the minimum capital requirement for the expanded credit license and to support the business at launch. After the balance-sheet date, in February 2026, the parent signed an intercompany credit facility of up to NIS 50 million to fund the start of operations, and also provided a guarantee framework for the activity.
This is no longer theoretical capital. It is an open funding line, with a named destination, into a business that still has no return history. And there is an even more important nuance in the business-separation arrangement with Ayalon. Subject to approvals, Ayalon may itself become part of Glovaltak Finance's funding sources and may even acquire up to 20% of its shares. In other words, the documents already open the door for cash generated inside Ayalon not only to move upward as dividends, but later to be redirected into a new credit platform as well.
The second move is Ayalon Gemel. Here the filing does not provide an explicit capital figure the way it does for Glovaltak Finance, and that is precisely the point. We know the move advanced, that the license and control-permit application was filed in March 2025, and that by the end of March 2026 a license had been granted to Ayalon Provident Funds together with an updated control permit for the controlling shareholders. But there is still no hard disclosure quantifying how much capital will actually be required to turn that license into a business with meaningful commercial weight. So there is no basis for a hard numeric claim yet, but there is a clear basis to note that this is another regulated vertical likely to consume setup, operating effort, and possibly capital before it produces return.
What matters is that these uses now compete for the same surplus pool. Every shekel that comes up from Ayalon, or that is raised in the market above it, can go to at least three different places:
- Back to shareholders through dividends.
- Into lower leverage and stronger parent-level flexibility.
- Into newer platforms such as Glovaltak Finance and Ayalon Gemel.
That is not a contradiction. But it does mean the debate around weSure in 2026 will no longer be only whether Ayalon keeps generating earnings. It will be whether group management knows how to decide which use of capital comes first.
Conclusion
The correct read on weSure after 2025 is that Ayalon already generates both profit and distributable cash, but once that cash moves up it enters a far more complex allocation process. In 2025 we saw it support shareholder distributions, the full repayment of the old acquisition bank loan, and the opening of new growth platforms. At the same time, we also saw debt and equity raised at the parent and fresh equity raised inside Ayalon itself.
That leads to two conclusions at once. On the one hand, weSure's flexibility is better than it used to be. The old bank loan is gone, solo cash is meaningful, and Ayalon has already proved it can distribute. On the other hand, that flexibility is no longer available only for shareholders. It now sits opposite the capital demands of non-bank credit, provident-fund activity, and potentially a more direct connection between Ayalon's capital generation and the funding of new platforms.
The bottom line is simple: Ayalon generates the cash, but weSure Global Tech allocates it. So the next question is not only how much more dividend Ayalon can send upstream, but how much of that cash will really remain free after payouts, debt decisions, and the buildout of businesses that still have not proved their returns.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.